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ABBREVIATIONS 
 
 
 
 
 
 
MELD        - Model for end stage liver disease 
 
 AUDIT - Alcohol use disorder identification test 
 MAST         - Michigan alcohol screening test 
 CRP - C-reactive protein 
SHT             - Systemic hypertension 
 
DM - Diabetes mellitus 
 
 
ESR             - Erythrocyte Sedimentation Rate 
 
 
IL-1 - Interleukin 1 
 
 
IL-6 - Interleukin 6 
 
 
 TNF alpha  - Tumor necrosis factor  alpha 
 
TGF-β - Transforming growth factor beta 
 
 
INR - International normalized ratio 
 
 
PT - Prothrombin time 
 
 
apTT - Activated partial thromboplastin time 
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INTRODUCTION: 
 
 
Ancient world had known well about the liver and diseases associated with liver. 
Egyptian scriptures and books of Talmud described about the problems with the 
liver and remedies associated with altered function of this essential organ. The 
word ‘cirrhosis’ is actually derived from Greek medicine and means that diseased 
liver with orange yellow in colour. 
 
Cirrhosis of liver which is having characteristic histological features resulting 
from various insult or injury to this organ whatever it would be, account for fourth 
major cause of mortality worldwide, and one of the leading cause of mortality in 
India.  
 
Since the diagnosis of liver diseases went through various stages of development 
from the ancient period such as ultrasonogram abdomen portal doppler study, CT 
scan of abdomen, OGD scopy and recently developed fibro-scan which is a non-
invasive modality for the diagnosis of cirrhosis, still History and Clinical 
examination are much more important in diagnosing liver disorders while coming 
across the evaluation of liver involvement, either primary or secondary to other 
systemic disorders.  
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To aid this evaluation further, various scores have been devised for the bed side 
identification of quantum of injury and to decide on therapeutic options whether 
liver transplantation needed or still medical management will be effective for 
decompensated and compensated liver diseases respectively.  
 
Of these, scores currently in use are modified child pugh score and model for end 
stage liver diseases score. The modified child pugh score of 7 and above signifies 
the need for liver transplantation and scores below 7 indicates medical 
management which can sustain the process of liver injury and associated 
complications. The model for end stage liver diseases score of 18 and above 
indicates poor prognosis concerned for liver diseases. 
 
Though various sequential pathogenic processes are involved to end in final stage 
of cirrhosis such as fatty liver, alcoholic hepatitis and fibrosis , one of mechanism 
for the progression of spectrum of pathological changes is inflammatory process 
upon which treatment modalities are proved to be effective also.  
 
Various inflammatory marker are involved in this process such as IL 1, IL 6, 
TNF-α, IL-1β, IL-2R, IL-8. Of these I have taken serum interleukin 6 as a 
Inflammatory marker for liver diseases particularly liver cirrhosis since elevated 
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level of this marker is significantly proved in studies. Moreover, this elevation is 
independent of aetiology such as alcoholism and viral infections and etc.  
 
Here one of above mentioned scoring system named child pugh score is correlated 
with level of interleukin 6 in patients with liver cirrhosis to facilitate the 
assessment of disease severity. If elevated level can be found statistically 
significant in this study, this marker even can be used as surrogate marker in 
assessment of disease severity in liver cirrhosis of various causes. 
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AIMS AND OBJECTIVES: 
 
 
 
 
 
 
 
 
 
 
 
 
To estimate SERUM INTERLEUKIN 6 level in patients with LIVER 
CIRRHOSIS of any cause 
 
 
 
 
 
To find out the CORRELATION BETWEEN SERUM 
INTERLEUKIN 6 LEVEL AND CHILD PUGH SCORE in assessing 
DISEASE SEVERITY 
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REVIEW OF LITERATURE: 
 
 
 
Physicians have well known problems with liver from the olden period that details 
have been mentioned in lot of age old literatures. Egyptian scriptures mentioned 
about liver diseases with explanations and references on medicine. Talmud books 
described issues about liver and liver diseases. About 1500 years ago middle east 
areas were reported to know about treatment modalities of various illness about 
1500 years ago. 
 Here I am going to discuss about “correlation of increasing levels of serum 
Interleukin 6 in liver cirrhosis patients with child pugh score to assess the disease 
severity with available references. 
 
CIRRHOSIS 
 
The word "cirrhosis" is actually coined in greek medicine and means that orange 
yellow colour of the diseased liver. Laennec also coined the name cirrhosis while 
he was working for stethoscope well before knowledge about this entity was 
described in the middle period of medicine. Details about shrunken liver were 
given in various ancient medical scriptures in detail including their management. 
[1] 
Cirrhosis is actually defined as a disease process in which fibrosis and nodule 
formation are the major components. There are so many causes for cirrhosis, but 
ultimately leading to same end result that is cirrhotic process. Liver can react to 
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the injurious processes in multiple ways of which liver lobule collapse and 
formation of fibrous septa which is diffuse in nature are the important 
pathological processes. Another response from the liver which is important is 
nodule formation.  
So whatever the cause for the liver injury, the final end histological picture is 
supposed to be ultimately unique.  Necrosis of liver hepatocytes is usually 
followed by fibrotic process.  Portal to portal bridging process occurring in zone 1 
of liver histology is interface hepatitis which is actually the key process.  Further 
collectively occuring necrotic processes leads to the formation of central to portal 
bridging process. Ultimately loss of cell mass in the liver leads to the formation of 
nodules. This nodular architecture of liver actually disturbs the original structure 
of liver and full blown cirrhosis picture will develop later on. 
The complex process involving several key components in particular are the 
stellate cells, cytokines, and proteinases and their inhibitors the important 
components requiring for the multistep process of organization of normal liver to 
fibrotic liver and finally formation of cirrhosis. Cytokines play an important role 
in the stimulation stellate cells in this complex process. These are TGF-1b, IL1b 
and TNF. Byproducts of lipid peroxidation also involved in this complex process. 
Alcohol metabolism which gives rise to acetaldehyde as an intermediate taking 
part in this processes also. 
Formation of matrix and its fate and discrepancies involved in this process play a 
major role in this complex process. Fate of matrix will be decided by those  such 
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as metallo proteinases, tissue inhibitors of metallo proteinases  and enzymes like 
stromelysin .There is alteration of interstitial matrix in such a way that normal 
basement membrane  is degraded more and  type collagen present in the 
interstitium will be degraded less in terms of amount and speed. These are the 
important pathological changes occurring during liver injury.  
Activation of stellate cell leads to the formation of myofibroblast which is 
morphologically similar, but functionally different from stellate cell and 
contractile function of these myofibroblast is well described.  
This function is expressed well over sinusoids leading to the local constriction and 
regulation of blood flow is attained well thereafter. This process is accomplished 
by two more biochemical substances such as nitric oxide and endothelin. 
Contraction is facilitated by decrease in nitric oxide level and increase in 
endothelin level [8, 9].  
The Kupffer cells are important in the production of certain cytokines such as 
TNF-a, IL1 and IL6 and also produced by hepatocytes to the smaller extent.  
Liver is involved in the clearance of these circulating cytokine and failure of this 
process leads to the level of certain cytokines to be elevated. This part of 
discussion is important since this could be probable mechanism for the elevation 
of certain cytokines in liver cirrhosis. Certain cytokines are involved in giving 
negative effect for regeneration of liver cells. These are IL6, IL1 and TNF [10]. 
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CLASSIFICATION OF CIRRHOSIS 
 
Morphological classification 
                                      
Morphologically cirrhosis is classified into macro-nodular cirrhosis, micro-
nodular cirrhosis and mixed type which contains both the components of micro 
and macro nodular cirrhosis.  
                                
 
                                               
                               MECHANISM OF CIRRHOTIC PROCESS 
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HISTOLOGY OF MICRO-NODULAR CIRRHOSIS 
 
 
 HISTOLOGY OF MACRO-NODULAR CIRRHOSIS 
 
                
27 
 
Etiological classification 
 
While mentioning about causes for cirrhosis liver, Viral hepatitis is particularly 
important. It is caused by Hepatitis b virus and hepatitis c virus and occasionally 
by the combination of Hepatitis b and d virus called delta virus. Alcohol is the 
important etiological factor involved in the causation of cirrhosis and is separately 
discussed below.  
Metabolic causes like Wilson’s disease in which abnormal copper metabolism is 
involved in the pathological process of cirrhosis formation also well known. Other 
metabolic causes such as type 4 glycogenolysis, congenital tyrosinosis, non 
alcoholic steatohepatitis and α -1 antitrypsin deficiency also well described as 
causes for cirrhosis. Cholestatic conditions either intrahepatic cholestasis or extra 
hepatic cholestasis is important causes and needed some invasive investigation to 
get diagnosed. Conditions causing obstruction to the blood flow from the liver 
such as Budd Chiari syndrome, occlusive disease of the venous system and 
constrictive pericarditis are also etiological factors for hepatic cirrhosis.  
Autoimmune disease of the liver is also described to end in cirrhotic process of 
liver. This condition may be diagnosed with various autoimmune antibodies such 
as antinuclear antibodies, anti-smooth muscle antibodies and anti LKM antibody 
etc. Various toxins are described in the process of cirrhosis formation. Arsenic 
and phosphorus poisoning and therapeutic agents like methotrexate and 
amiodarone are known to cause cirrhosis liver. Indian childhood cirrhosis is rare 
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but known entity to cause liver cirrhosis.  
Syphilis causes cirrhosis in neonates but not in adults. Schistosomiasis is another 
infectious cause reported to cause this disease process. Brucellosis, tuberculosis 
and sarcoidosis which causes focal granuloma, heal with fibrosis, but the liver 
does not show nodular regrowth. Cryptogenic cirrhosis is another rare entity in 
which the etiology is not known. 
 
Diagnosis of cirrhosis 
                             
For the diagnosis of cirrhosis radiological investigations are much more important 
routine investigations. Nodules in the liver can be best suggested by 
ultrasonogram abdomen, but still it is not confirmatory for the diagnosis for 
particular liver pathology expected. Portal vein diameter and phasic flow changes 
in the portal vein are specific parameters for the detection of portal hypertension. 
In our study Portal vein diameter of greater than 13mm is considered to be a cut of 
value for the presence of portal hypertension. With both of these methods 
sensitivity goes up to 87% [11, 12].  Computerized Tomography is another 
important investigation used to diagnose presence of cirrhosis and its 
consequences. 
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    CT SCAN SHOWING CIRRHOSIS AND ASCITES  
Liver biopsy is ultimately confirmatory for the identification of pathological 
changes, particularly cirrhosis. But sensitivity of this invasive method is around 
62% only. The Stains commonly used for the histopathology are collagen and 
reticulin. Van Giesen stain is used for the identification of scars, Specific portal 
zones. Elastin and silver stain used for sinusoids and reticulin fibres respectively. 
Cirrhosis results in two major events apart from causing other features depending 
on the cause. On history, details regarding stomach pain, fatigue ,loss of appetite 
,loss of weight, nonspecific gastrointestinal symptoms, yellowish discoloration of 
conjunctiva, Color of urine and altered color of faeces, Bilateral swelling of lower 
limbs and abdomen, bleeding  from nose, gums, skin and alimentary tract, 
decreased libido should be asked about.  
Past history about other relevant significant history about diabetes mellitus, 
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systemic hypertension, coronary heart disease, kidney disease details of drugs 
ingested and blood transfusion before 1986 and 1992 to rule out possibility of 
hepatitis B and hepatitis C should be asked. History of any particular illness 
running in the family should be asked. History of alcoholism consumption should 
be described in detail. 
The clinical examination is important and should be correlated with history. More 
focus on nutritional status of the patient is needed and may give clue regarding 
chronicity of the problem. If the patient is febrile importantly spontaneous 
bacterial peritonitis should be ruled out and common causes of febrile illness 
should be also borne in mind. Details regarding fetor hepaticus, jaundice, 
pigmentation, purpura, should be also noted.  
Finger clubbing which may occur in inflammatory bowel diseases may narrow 
down the diagnosis if correctly identified. Other Important signs such as 
koilonychia due to hypo albuminemia, spider nevi which also mimic like venous 
star, erythema involving inner hand, breast enlargement, reduced testicular size 
with loss of testicular sensation, Parotid gland enlargement which is specific for 
male alcoholics.  
 
Dupuytren’s contracture and distribution of body hair may direct the physician to 
search for other signs of liver cell failure .Note regarding peripheral edema should 
be made and cardiac, renal other causes of edema also should be ruled out. 
On Per Abdomen examination evidence for free fluid in the abdomen like shifting 
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dullness or fluid thrill should be elicited. If not elicited with conventional methods 
puddle sign may help us to detect minimal fluid as little as 120 ml. Abdominal 
wall veins if noted their direction should be specified since pattern in Portal 
hypertension is just the exaggeration of normal pattern and should be examined in 
sitting or standing posture if possible.  
Liver span should be measured since it may be reduced in cirrhosis of liver. 
Palpation of the spleen should be done since its presence signify the presence of 
portal hypertension. If not palpable, try to find splenic enlargement with 
percussion methods like Nixon’s, castell’s and traube’s method. 
Central nervous system examination is critical since it helps in the diagnosis of 
hepatic encephalopathy and may change the direction of the management, 
particularly drug prescription. Tests to detect minimal hepatic encephalopathy can 
be done at bed side and the presence of asterixis should not be missed and other 
causes of flapping tremor should be also borne in mind. 
All routine investigations such as Complete blood count, Renal function tests, 
liver function tests which includes Total bilirubin, direct bilirubin, indirect 
bilirubin, Aspartate aminotransferase, Alanine amino transferase, alkaline 
phosphatase, Gamma glutamyl trans-peptidase, total protein, serum albumin level, 
serum globulin level and chest x ray, electrocardiogram, urine analysis should be 
done. Prothrombin time including INR, apTT should be done.  
If ascites present, ascitic fluid analysis should be sent with aseptic diagnostic 
paracentesis. Daily weight chart and abdominal girth chart should be maintained. 
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Simple urine analysis for presence of albumin in the urine may give additional 
clue to the diagnosis. 
       Various antibodies are important if diagnosis of autoimmune hepatitis is 
contemplated. Anti-nuclear antibodies, anti-smooth muscle cell antibodies, anti 
mitrochondrial antibodies and anti LKM -1 antibody can be helpful in ruling out 
this condition. Viral markers such as HBs Ag, anti-HCV and other markers of 
hepatitis should be done if viral hepatitis comes across the diagnostic work up. 
Alpha fetoprotein which may be elevated in malignancy should be done if 
relevant. 
Endoscopy may help to grade varices and to plan treatment also. Hepatic CT scan 
or ultrasound to confirm the presence of cirrhosis is ideal in the diagnostic work 
up.  Use of Invasive procedures is limited in the diagnostic work up particularly if 
diagnostic work up is inconclusive after all possible diagnostic tests have been 
done. 
History of Mood disturbances, altered sensorium and loss of sleep are specified by 
attenders, central nervous system involvement can be better evaluated with EEG. 
Since most of the patients included in our study are alcoholic, discussion related 
with alcohol induced liver diseases is done here in detail. 
Alcohol is the important causative factor worldwide. During the period of 10,000 
B.C Alcohol have been used for its euphoric and recreational effects [2].  In Iron 
evidences were found for utensils used to prepare alcohol related drinks about 
5000 B C [3]. In the Bible also evidences for alcohol use were found of that the 
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holy messenger Noah used to drink alcohol [4].Increase in taxes have been laid 
upon alcohol and related beverages in England in 1726  due to its increasing side 
effects on health.[5]. Once prime minister of Great Britain have talked and 
enumerated regarding the evil effects of alcohol to working people his country in 
a formal meeting advised them to quit from drinking. Ultimately strict laws were 
enhanced there to restrict their use and reduce their effect on health and sickness 
absenteeism.[6,7]. 
Liver damage doesn’t develop in all those taking alcohol. Only 10-15% of those 
taking alcohol will develop fibrotic changes in the liver [14]. If males consume 
alcohol for about nearly eight year period, they may develop cirrhotic changes 
[15].The danger dose in most individual is higher than 80 g of alcohol /day. 
Religious beliefs, customs, cost of the alcohol.  
Economic status of the individual largely plays a role in the determination of the 
prevalence of alcoholic liver disease. If cost of the alcohol is lower, more socio 
economic group will be affected. Moreover, the type of beverage has no role in 
quantum of liver injury, but its alcohol content accounts. Alcohol content of 10 
grams will be present in 30 ml of whisky, 100ml of wine and 250 ml of beer. 
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                    HEPATO-BILIARY EFFECTS OF ALCOHOL 
 
Comparatively women are more prone to ill effects of alcohol more than males. 
They usually have the propensity for hastened pathological processes to cirrhosis 
much earlier than o males get their ill effects. Frequent relapses are also reported 
and the real reason behind this propensity is still under investigation. Even if they 
stop alcohol they may show disease progression [16].   
Genetic studies have been carried out to reason out rate of elimination of alcohol 
in different people and gene polymorphism of enzyme system could be the 
probable cause [17].The rate at which alcohol is removed from our body is 
decided by different iso-enzyme pattern of enzyme mentioned below in the picture 
description. Actually alcohol supplies nutritionally valueless calories. 1 gram of 
alcohol supplies 7 calories.200 gram supplies approximately 1400 calories.  
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ALCOHOL METABOLISM IN THE LIVER. ADH, ALCOHOLDEHYDROGENASE; 
ALDH, ALDEHYDE DEHYDROGENASE 
 
Hepatotoxic effects of acetaldehyde: 
1. Increased lipid peroxidation 
2. Binding with plasma membranes 
3. Problems of electron transport chain of mitochondria 
4. Inhibition DNA repair process 
 5. Micro tubular functional abnormality 
6. Protein adduct formation 
7. Activation of complement Stimulates superoxide formation by Neutrophil     
produces super oxide radicals due to complement activation. 
8. Hastened and altered synthesis of collagen 
 
Morphological changes occuring in alcoholics are divided into,  
                                         1. Fatty liver 
                                         2. Alcoholic hepatitis 
                                         3. Cirrhosis 
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HISTOLOGY OF ACUTE ALCOHOLIC HEPATITIS.  
 
Alcoholic hepatitis histologically described with the following features such as 
Mallory bodies, Balloon degeneration, Sclerosing hyaline necrosis, Acidophilic 
bodies, Mallory bodies, Giant mitochondria. 
 
 
          HISTOLOGY OF CIRRHOSIS   
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Cirrhosis in alcoholics is classically micro nodular. But macro nodular pattern of 
cirrhosis will develop along with micro nodular pattern with the attainment of 
reduced fibrosis. Histologically it is very difficult to ascertain the cause of 
cirrhosis when this end stage of histological picture results.  In approximately one 
third of alcoholics there will be increased hepatic iron. 
Screening of alcohol use and its overuse can be better detected by specific 
questionnaires which used to ascertained dependence of substance use and its 
abuse and these include the CAGE [18] ,The MAST and The AUDIT[19]. 
The CAGE questionnaire includes the letters such as C, A, G and E. Each 
alphabet denotes one question to be asked from the patient who should answer in 
the presence of observer. It He says ‘ yes’ for one question it signifies alcohol use 
and if answered for two questions it is concluded that alcohol dependence status 
to further evaluated in the given patient and treatment direction may be changed 
further. 
Another questionnaire used in the screening of alcohol abuse alcohol dependence 
is AUDIT questionnaire. This is difficult to use at bed side, but valuable in 
screening alcoholics. 
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Score of our study to be correlated with serum interleukin level in assessing 
disease severity is child pugh score which includes scores from five to fifteen. It 
contains the following entities such as prothrombin time in seconds, serum 
albumin level, and serum bilirubin level. Scores of 5 and 6 being Child class A 
means the score of five and six and said that patient is in compensated state of 
cirrhosis. Child class B includes scores of seven to nine, and Child class C 
includes scores of ten to fifteen. 
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This scoring system was initially devised to stratify patients into risk groups prior 
to undergoing portal decompressive surgery. The Child-Pugh score is a 
reasonably reliable predictor of survival in many liver diseases and predicts the 
likelihood of major complications of cirrhosis such as bleeding from varices and 
spontaneous bacterial peritonitis. It was used to assess prognosis in cirrhosis and 
to provide the standard criteria for listing liver transplantation (Child-Pugh class 
B).  
Patient survival rate at one and two year can be better with this scoring system. 
For Class A, it is100% and 85% respectively; for Class B It is 80% and 60% 
percent respectively and for Class C it is 45% and 35% respectively[24,25]. 
Patients with a Child pugh score of less than 8 had a higher survival rate at 90 
days compared with patients whose score was 8 or greater(95 versus 30 
percent)[27]. 
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Another similar classification system related with child pugh classification and 
not used in our study is Child turcotte classification system which was originally 
proposed more than 30 years ago [28]. It was originally designed for predicting 
the outcome after surgery for portal hypertension in patients with cirrhosis. The 
variables used are level of ascites, level of encephalopathy, serum bilirubin level, 
serum albumin level and nutritional status of the patient [28].A modified version 
of child’s score which was discussed and used in our study  was proposed 20 
years ago [29]. 
 
 
 
 
 
 
 
 
CHILD PUGH SCORE 1 2 3 Score Child cl 
 Ascites None slight moderate 5-6 A 
Encephalopathy None Grade1 
to 2 
Grade 3 to 
4 
7-9 B 
 Serum bilirubin <2.0 2.0-3.0 >3.0 10-
15 
C 
Serum Albumin >3.5 3.5-2.8 <2.8 
PT(sec inc more than control) 0-4 4-6 >6 
CHILD TURCOTTE SCORE A B C 
 Ascites none Easily 
controlled 
Poorly 
controlled 
 Encephalopathy none mild advanced 
Serum bilirubin <2.0 2.0-3.0 >3.0 
Serum Albumin >3.5 3.5-3.0 <3.0 
Nutrional status excellent good Poor 
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The most used one and simple to use is Maddrey (modified) Discriminant 
Function score [20]. It contains two variables such as difference in prothrombin 
time and total bilirubin in mg/dl. Here is the formula to calculate modified 
discriminant function. 
         Modified Discriminant Function = 4.6* (PT patient-PT control) +serum 
bilirubin. It indicates poor prognosis if score is greater than thirty two in alcoholic 
hepatitis. One month mortality rate is calculated with this formula that if score is 
greater than or equal to 32 are at increased risk of mortality which is between 
thirty and fifty percent [21]. 
Other system has also been proposed to stratify patients and includes serum 
bilirubin, serum creatinine and International normalized ratio. It is called model 
for end stage liver disease score [22].The formula used to calculate MELD score 
is as follows, 
Model for end stage liver disease score = 3.8 * loge (serum total bilirubin) + 11.2 
* loge (International normalized ratio) + 9.6 *loge (serum creatinine ) + 6.4 
 
If MELD score is greater than 18, it indicates poor prognosis in alcoholic 
hepatitis. 
One more score is there to assess the prognosis of alcoholic hepatitis. It is 
Alcoholic Hepatitis score of glasgow. Variables used are patient’s age, blood urea 
level, white ell count, PT ratio and bilirubin in mg/dl. If score is greater than 8, it 
is considered to be poor. 
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Interleukin 6 
                      Interleukin-6 is the serum substance of which level is correlated in 
our study with modified child pugh score in liver cirrhotics. Certain properties of 
Interleukin 6 are discussed here. 
 
  
CRYSTAL STRUCTURE OF IL-6 
 
Interleukin-6, a monomer of 184 amino acids, is a multifunctional pleotropic 
cytokine having important function in the regulation of immunity, inflammatory 
reaction in various sites of our body, haematopoiesis and cancer biosynthesis. Its 
functions are shared by other cytokines like leukemic inhibitory factor, ciliary 
neutrotrophic factor, and oncostatin [30]. 
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                CHEMICAL STRUCTURE OF IL6 
  
Interleukin 6 has its own exclusive system which consists of two components such 
as a Receptor specific for IL-6 andgp130, the common signal transducer of 
cytokines related to IL-6[31, 32, 33]. The transduction through gp 130 is 
processed through two important pathways of which the JAK STAT pathway and 
the RAS MAP kinase pathway and their individual structure and function 
specifically identified [34]. 
Both anti-inflammatory and pro-inflammatory properties of this cytokine are well 
elucidated .Gene is located in 7 p 21 chromosome in human beings [35]. Both T 
cells and macrophages release interleukin 6 to augment immune response. 
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Interleukin-6 is also important in fighting against infection, One important 
bacteria, pneumococci is inhibited with the help of interleukin 6.This study was 
conducted in mice and proved [36]. During muscle contraction it has been shown 
that level of this cytokine will be elevated. So it is also called myokine [37]. 
Mobilization of substances into cell will be accomplished with the help of this 
cytokine while doing exercise and hormone like action is expressed here. [38]
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           IL-6 WITH ITS RECEPTOR (IL 6R IN BLUE) 
 
Osteoclast is formed due to stimulation by interleukin 6 which production by 
osteoclast is well documented. Middle layer of blood vessel also produce 
Interleukin 6.It inhibits other cytokine such as TNF-α and IL-1 and so exhibiting 
anti-inflammatory action which also done with stimulation of Interleukin 1 and 
Interleukin 10.It is one of the important mediator of acute phase response and of 
fever. It can invade central nervous system and start prostaglandin synthesis 
thereby regulating body’s temperature [39]. 
Macrophages also secrete IL-6 in response to Specific microbial molecules. 
Cloning process well utilizes Interleukin 6 for the growth of cells and proved to be 
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effective. Estrogen use in the treatment of osteoporosis especially in old aged 
Women. Obese individuals are known to have higher level of interleukin 6 and 
subsequent studies showed that adipocytes could be also a source of this cytokine 
[40]. 
IL-6 is involved in many diseases such as diabetes mellitus [41], fat metabolism 
atherosclerosis [42], depressive illness and other psychiatric illnesses [43], 
alzhiemer’s disease [44], lupus disease [45], cancer of prostate gland [46], and 
rheumatoid arthritis and related disorders [47]. Patients with advanced malignancy 
are proved to have elevated level of interleukin 6 [48]. 
Synthesis of steroids also is controlled by this cytokine since its action on 
hypothalamus and pituitary gland could be the possible mechanism. Stimulation 
of growth hormone secretion and inhibits TSH secretion are also part of the 
endocrine function of this hormone.  
During stress its level is elevated and is positively controlled by catecholamines. 
In steroid withdrawal syndrome there will be elevate level of Serum Il-6. Normal 
process of aging is also involved elevated level of Interleukin 6[49]. 
 
Correlation of IL-6 level with CHILD PUGH score 
 It is found that Serum Interleukin 6 level is elevated in liver cirrhosis. In one 
study both cases of viral hepatitis and alcoholic liver diseases were included as 
causative factors. Serum Il-6 values are increased with progressive detioration of 
liver function. Interleukin 6 level in patients with child class C higher than with 
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child class B and A [50].Cirrhosis patients are reportedly known to have elevated 
level of Interleukin 6[51]. 
Positive correlation has been mentioned in one study that several serum 
inflammatory cytokines including IL-6 and severity of liver cirrhosis are well 
described. Moreover this correlation is independent of etiological factors like 
alcoholic liver diseases and viral hepatitis [52].In one study increasing values of 
IL-6 and TNF alpha are proved in concordance with severity of cirrhosis. For IL 6 
child class A/B/C-(8.8/12.3/18.9pg/ml) respectively and for TNF alpha 
(36.9/42/51.7 pg/ml)[53]. 
  The mechanism of raised serum IL-6 level in patients can be explained from the 
details of following study. Decreased hepatic uptake of Interleukin 6 is a reason 
due to which increase in the level of serum Interleukin 6 observed in cirrhosis. 
Healthy liver extracted 43% of portal vein derived IL-6, but cirrhotic liver only 
extracted 6.3% of IL-6 and showing that decreased removal by cirrhotic liver. 
Cause of liver cirrhosis did not affect hepatic removal rate telling that elevate 
level of Interleukin 6 synthesis in liver cirrhosis [54]. 
In another study it was highlighted that increased levels of serum IL 6 in patients 
with liver diseases may be protective, since IL-6 deficient mice is reported to have 
higher propensity for alcohol mediated injury, and exposure with IL-6 improved 
hepatic steatosis in these IL-6 deficient mice [55].To support this above 
mentioned issue, another study saying that in the protection of ethanol mediated 
liver injury IL-6 plays an important role. The expression of anti-apoptotic Bcl-2, 
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Bcl-xL proteins in the liver of chronically ethanol fed mice and human ALD is 
induced by elevated level of IL-6.So in the treatment of acute fulminant hepatic 
failure IL-6 could be used [56]. 
 
Serum concentration of IL-6 and IL-18 may be useful to discriminate cirrhotic 
patients with and without MHE, since there is a positive correlation between the 
level of IL-6 and IL-18 in patients with hepatic encephalopathy [57]. So by 
proving increasing levels of serum interleukin 6 in patients with and without 
portal hypertension, we can say that serum IL6 can be used as a marker with 
which severity of liver cirrhosis can be better assessed apart from other markers 
used in the assessment of severity of liver diseases. 
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MATERIALS AND METHODS: 
 
 
 
The center of study is Institute of Internal Medicine, Madras Medical College & 
Rajiv Gandhi Government General Hospital, Chennai  – 3. 
 
Study Design : Cross sectional study. 
 
 
 
Venue : Rajiv Gandhi Government General Hospital, Chennai 
 
 
 
 
 
Collaborating Departments: 
 
 
Institute of Biochemistry, MMC&RGGGH, Ch-3 
 
 
Institute of Medical gastroenterology, MMC&RGGGH, Ch-3 
 
 
Barnard Institute of Radiology, MMC&RGGGH, Ch-3 
 
 
 
 
 
 
Duration :  Study was conducted from June 2012 to November 2012 
 
 
 
 
 
About fifty patients who attended our outpatient or got admitted in emergency 
department with history of Abdominal pain,  Abdominal distention, 
Swelling of legs, jaundice, yellowish disc of urine reduced urine 
output, haemetemesis, melena,  haemetochezia, fever,  chills, rigor, 
loss of weight,  loss of appetite, altered sensorium, mood changes 
and sleep disturbances were selected randomly. A complete history was 
taken either from the patient or his/ her attender including past  history of 
jaundice, DM, hypertension, coronary artery disease, seizures, Cerebro vascular 
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accidents, COPD, history of prior surgery, malignancy, blood transfusion. His/her 
personal habits were enquired. 
 
A complete physical examination was done with monitoring of vitals 
(temperature, pulse rate, respiratory rate and blood pressure) every day or 
frequently as the patient condition demanded.  A battery of blood investigations 
were done including renal functions, liver functions test, Complete blood count, 
ECG,  HBs Ag, HIV, Anti HCV, prothrombin time, apTT, Urine analysis Lipid 
profile, serum IL 6, Chest X ray, USG abdomen, Portal Doppler study, Ascitic 
fluid analysis and OGD scopy. 
 
Serum Interleukin 6 level was measured by ELISA method. Pyrogen/Endotoxin 
free collecting tubes are used for sample collection. Serum is removed rapidly 
and carefully from the red cells after clotting. Following clotting, centrifugation 
done at approximately 1000 x g for 10 min and Serum removed. Shortly after 
collection, samples are aliquoted (250-500μl) to avoid repeated freeze-thaw 
cycles and stored frozen at –70°C.  
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The sensitivity, minimum detectable dose of IL-6 using this IL-6 ELISA kit is 
found to be less than 2pg/ml. The assay recognizes both natural and recombinant 
human IL-6. To define the specificity of this ELISA several proteins were tested 
for cross reactivity. There was no cross reactivity observed for any protein tested 
(IL-1a, IL-1b, IL-10, IL-12, IFN gamma, IL-4, TNF alpha, IL-8 and IL-13).  
The overall intra-assay coefficient of variation has been calculated to be 4.2%. 
The calculated overall inter-assay co-efficient of variation was 7.7%. This 
immunoassay is calibrated against the International Reference Standard NIBSC 
89/548. NIBSC 89/548 is quantitated in International Units (IU). 1IU is 
corresponding to 11pg of this given ELISA kit measurement of IL-6. 
 
 
 
Inclusion Criteria:  
    
                                      Recently diagnosed/Known cases of cirrhosis of any cause  
with or without portal hypertension. 
 
Age group: 25-50 years. 
 
              
 
Exclusion criteria: 
 
1. Cirrhosis with SBP 
2. Hypertensive patients 
3. Diabetic patients 
4. Dyslipidemic patients  
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5. Connective tissue disorders 
6. Any chronic inflammatory condition 
7. Autoimmune liver diseases 
8. Malignancy/metastasis 
9. Haematological malignancy 
10. Known coronary artery disease patients 
Other co morbidities (COPD, pre-existing renal disease, thyroid disorders) 
 
 
 
Statistical Analysis Plan: 
 
 
Data analyzed using statistical package - SPSS EPI INFO Software 
 
 
 
 
 
Consent 
 
 
All participants / attenders gave written informed consent. 
 
 
 
 
 
Ethical Committee Approval 
 
 
Institutional Ethics Committee of Madras Medical College approved the study 
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OBSERVATION AND RESULTS: 
 
 
In the study of fifty cases of Cirrhosis of varying causes admitted in Madras 
Medical College & Rajiv Gandhi Govt. General Hospital, Chennai, the 
following observations were made in sex incidence, age distribution, 
distribution of duration (with Child class, Child score and Mean IL 6 level 
respectively), Child class with Mean IL6, Child class with Variceal grading, 
Child class with Mean Portal vein diameter, Child class with Mean SAAG, 
Child class with serum albumin, Child class with Mean total protein, 
Child class with Mean Hb %, Child class With Mean Platelet, Hb % with 
Mean IL 6, Platelet with Mean IL 6, Prothrombin time with Mean IL 6, No of 
HbsAg Positives and negatives, No of HCV Positives and Negatives, Serum 
albumin with Mean IL 6, SAAG with Mean IL 6, Portal vein diameter with 
Mean IL 6, Variceal grading with Mean IL 6 and Child class With Hb% as 
follows: 
 
 
 
 
 
Total number of patients : 50 
 
Total number of males : 
 
47 (94%) 
 
Total number of females : 
 
  3 (64%) 
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Age distribution 
 
                              Age                     No of patients                             Percent 
  
< 30 2 4.0 
 
-40 13 26.0 
 
> 40 35 70.0 
 
Total 50 
 
100.0 
 
                                 
                                       TABLE NO: 1 
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Patients with Age between 40 -50 were around 35(70%) and Patients with age 
less than 30 were just 2 in number.  
So this study may tell u more about correlation of Child pugh score with 
Serum IL6 values in the age group of between40 and 50. 
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Sex incidence 
 
 
                               Sex                   Frequency                       Percent 
 Male 
47 94.0 
Female 
3 6.0 
Total 
50 100.0 
                                
                                                   TABLE NO: 2 
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Total number of males included in this study was 47 and females 3 accounting 
for 94% and 6% respectively. Since Prevalence of Alcoholism was 
significantly higher in our study population and particularly in Males, males 
are higher in number in our study. 
 
Duration of illness and Child class 
 
 
                   Duration in years 
  
Child Class 
Total A B C 
  
 
< 2 Count 6 7 3 16 
% within 
Duration in 
years 
37.5% 43.8% 18.8% 100.0% 
% within Child 
Class 
75.0% 53.8% 21.4% 45.7% 
2.5-4.0 Count 1 5 3 9 
% within 
Duration in 
years 
11.1% 55.6% 33.3% 100.0% 
% within Child 
Class 
12.5% 38.5% 21.4% 25.7% 
4.5-6.0 Count 1 1 7 9 
% within 
Duration in 
years 
11.1% 11.1% 77.8% 100.0% 
% within Child 
Class 
12.5% 7.7% 50.0% 25.7% 
> 6.0 Count 0 0 1 1 
% within 
Duration in 
years 
.0% .0% 100.0% 100.0% 
% within Child 
Class 
.0% .0% 7.1% 2.9% 
                             Total Count 8 13 14 35 
% within 
Duration in 
years 
22.9% 37.1% 40.0% 100.0% 
% within Child 
Class 
100.0% 100.0% 100.0% 100.0% 
 
                                                                            TABLE NO: 3 
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The p value is 0.065 
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Distribution of duration of illness with child class is explained here. Patient’s 
duration of illness around 2 years is higher among all other groups such as 
group of 2.5 to 4 years, 4.5 to 6 years and > 6 years. Comparision of 
distribution of duration with Child class is no statistically significant since P 
value is 0.065. 
 
Duration and child score 
 
 
                     Duration in years 
  
Child Score 
Total < 10 > 10 
  
 
< 2 Count 14 2 16 
% within 
Duration in 
years 
87.5% 12.5% 100.0% 
% within Child 
Score 
48.3% 33.3% 45.7% 
2.5-4.0 Count 8 1 9 
% within 
Duration in 
years 
88.9% 11.1% 100.0% 
% within Child 
Score 
27.6% 16.7% 25.7% 
4.5-6.0 Count 6 3 9 
% within 
Duration in 
years 
66.7% 33.3% 100.0% 
% within Child 
Score 
20.7% 50.0% 25.7% 
> 6.0 Count 1 0 1 
% within 
Duration in 
years 
100.0% .0% 100.0% 
% within Child 
Score 
3.4% .0% 2.9% 
                             Total Count 29 6 35 
% within 
Duration in 
years 
82.9% 17.1% 100.0% 
% within Child 
Score 
100.0% 100.0% 100.0% 
 
                                                               TABLE NO: 4 
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The p value is 0.505 
 
Comparision of distribution of duration with Child pugh score is done here. 
Patients with child score less than 10 in the duration group of 2 years are 
14(87.5%) and with greater than 10 is 2(12.5%). 
 
 Patients with child score less than 10 in the duration group of 2.5 to 4 years 
are 8 (88%) and with greater than 10 is 1(11%).  
 
Patients with child score less than 10 in the duration group of 4.5 to 6 years are 
6(66%) and with greater than 10 are 3(33%). Patients with child score less than 
10 in the duration group of greater than 6.5 years is 1 and with greater than 10 
is 1.  
 
This correlation is not statistically significant since the P value is 0.505. 
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DURATION AND mean IL6 
 
The p value is 0.061 
Comparison of duration with mean IL 6value is done here. Mean IL 6 value of 
Patients with duration of illness less than 2 years is 12.281. Mean IL 6 value of 
Patients with duration of illness 2.5 to 4 years is 14.278. Mean IL 6 value of 
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Patients with duration of illness 4.5 to 6 years is 17.067. Mean IL 6 value of 
Patients with duration of illness greater than years is 16.400. Higher number of 
patient is in the duration group of less than 2 years. This comparison is not 
statistically significant since the p value is 0.061. 
 
 
 
                                                TABLE NO: 5 
 
 
 
Duration in years                                  No of patients                             Mean IL 6(pg/ml) 
< 2 
16 12.281 
2.5-4.0 
9 14.278 
4.5-6.0 
9 17.067 
> 6.0 
1 16.400 
Total 
35 14.143 
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Child class and IL6 
 
P value is .001 
 
Here the comparison of Child class with Mean IL 6 value is done. Mean IL 6 
value of Patients with Child class A, B and C are 8.876, 13.041 and 
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18.612pg/ml respectively. Increasing values of Mean IL 6 are proved here if 
Child classis increasing from A to C. So main objective of our study is 
statistically significant since p value is 0.001 
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                                                                          TABLE NO: 6 
 
 
 
 
Child class and variceal grading 
 
 
P value is .001 
Here the comparison of Child class and variceal grading is done. Child class A 
having total number of patients 17 is observed here to have normal OGD scopy 
for 10 patients and variceal grading of 1 and 2 with number of patients each 3 
respectively.  
 
Child class 
                                     No of patients                               Mean IL 6(pg/ml) 
A 
17 8.876 
B 
17 13.041 
C 
16 18.612 
Total 
50 13.408 
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Child class C having total number of patients 16 is observed to have normal 
OGD scopy for 0 and grade 4 for 11 patients and grade 3  for 2 patients. So 
increasing values of variceal grading is observed if Child class is increasing. 
This correlation is statistically significant since p value is 0.001 
 
 
 
                                                        TABLE NO: 7 
 
Child Class   
Variceal Grade 
Total Normal 1 2 3 4 
 A Count 
10 3 3 1 0 17 
% within 
Child Class 58.8% 17.6% 17.6% 5.9% .0% 100.0% 
% within 
Variceal 
Grade 
62.5% 100.0% 25.0% 20.0% .0% 34.0% 
B Count 
6 0 6 2 3 17 
% within 
Child Class 35.3% .0% 35.3% 11.8% 17.6% 100.0% 
% within 
Variceal 
Grade 
37.5% .0% 50.0% 40.0% 21.4% 34.0% 
C Count 
0 0 3 2 11 16 
% within 
Child Class .0% .0% 18.8% 12.5% 68.8% 100.0% 
% within 
Variceal 
Grade 
.0% .0% 25.0% 40.0% 78.6% 32.0% 
                      Total Count 
16 3 12 5 14 50 
% within 
Child Class 32.0% 6.0% 24.0% 10.0% 28.0% 100.0% 
% within 
Variceal 
Grade 
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 
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Child score and Portal vein diameter 
 
 
Child class No of patients Mean PVD(mm) 
A 1 11.82 
B 17 13.29 
C 16 13.94 
Total 34 13.00 
                                                                                      TABLE NO: 8 
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The p value is .001 
 
Here the comparison of Child pugh score with Portal vein diameter is done. 
Mean Portal vein diameter is increasing if Child class increases.  
The mean Portal vein diameter of 11.82mm is obtained for child class A. The 
mean portal vein diameter of 13.29 mm is obtained for child class B. The mean 
portal vein diameter of 13.94 mm is obtained for child class C. The mean 
portal vein diameter of 13.00 mm is obtained for all patients in this study. This 
increase is statistically significant since p value for this comparison is 0.001 
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Child class and SAAG 
 
 
Child class No of patients Mean SAAG 
A 1 1.700 
B 17 1.859 
C 16 1.688 
Total 34 1.774 
                                              TABLE NO: 9 
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The p value is 0.449 
 
Here the comparison of Child class with mean SAAG value is done.  The mean 
SAAG value for child class A is 1.700. The mean SAAG value for child class 
B is 1.859. The mean SAAG value for child class C is 1.688. The mean SAAG 
value for all patients is 1.774.  
This correlation is not statistically significant since the p value is 0.449. 
Though the SAAG is very important to differentiate patients with and without 
portal hypertension, in our study it is not correlating well for the required 
work. 
 
Child class and Serum albumin 
 
Child class No of patients Serum Albumin(g/dl) 
A 17 3.582 
B 17 3.253 
C 16 2.650 
Total 50 3.172 
                                     
                                       TABLE NO: 10 
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The p value is 0 .001 
Here the comparison of Child class with mean Serum Albumin value is done. 
Serum albumin value decreases if child score increases from A to C. This 
correlation is statistically significant since the p value is 0.001 
Child pugh score and Mean Total protein 
Child class No of patients Mean Total protein(g/dl) 
A 17 6.41 
B 17 6.13 
C 18 5.71 
Total 50 6.09 
                                                              TABLE NO: 11 
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The p value is 0 .006 
 
 
Here the comparison of Child class with mean Total protein value is done. 
Serum Total protein value increases if child score increases from A to C. This 
correlation is statistically significant since the p value is 0.006 
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Child pugh score and Platelet count 
 
Child class No of patients Mean Platelet 
count(lac/cumm3) 
A 17 1.4929 
B 17 1.2971 
C 18 1.3931 
Total 50 1.3944 
                                    TABLE NO: 12 
 
 
 
The p value is 0 .675 
 
Here the comparison of Child class with mean platelet value is done. This 
correlation is not statistically significant since the p value is 0.675 
1.15
1.2
1.25
1.3
1.35
1.4
1.45
1.5
1.55
A B C Total
M
e
a
n
 p
la
tl
e
t(
la
c/
cu
m
m
)
Child class
Comparing Child class with mean Platelet 
count
Platelet
77 
 
 
IL 6 and Hemoglobin% 
 
Hb%                      No of patients                        Mean IL 6(pg/ml) 
< 6 11 15.064 
6.1-8 12 13.558 
8.1-10 14 12.871 
> 10 13 12.446 
Total 50 13.408 
                                                                  
                                                        TABLE NO: 13 
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The p value is 0.536 
 
Here the comparison of Hemoglobin with mean IL 6 value is done. This 
correlation is not statistically significant since the p value is 0.536 
 
Platelet count with Mean IL6  
 
 
 
 
 
 
 
                                          
TABLE NO: 14 
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Platelet 
count(lac/cumm3)                    No of patients                            Mean IL6(pg/ml 
<= 1 
15 13.740 
1-1.5 
18 13.361 
> 1.5 
17 13.165 
Total 
50 13.408 
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The p value is 0.939 
Here the comparison of Platelet count with mean IL 6 value is done. This 
correlation is not statistically significant since the p value is 0.939 
 
Prolongation of PT in sec with Mean IL6 
 
Prolongation of PT(sec)                                 No of patients                                Mean IL6(pg/ml) 
< 2 
28 11.011 
2.1-4 
15 14.760 
4.1-6 
6 19.233 
> 6 
1 25.300 
Total 
50 13.408 
                                                                    TABLE NO: 15 
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The p value is 0.001 
Here the comparison of PT prolongation with mean IL 6 is done. This 
correlation is statistically significant since the p value is 0.001 
 
 
 HbsAg Positivity and Negativity 
 
HbsAg No of patients 
Positive 3 
Negative 47 
                                       TABLE NO: 16 
 
 
HbsAg 
Positive(3)
Negative(47)
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HCV Positivity and Negativity 
 
HCV No of patients 
Positive 2 
Negative 48 
                                                      TABLE NO: 17 
 
Albumin and Mean IL 6 
 
Serum albumin(g/dl)                           No of patients                        Mean IL 6(pg/ml) 
< 2.8 
12 19.192 
2.8-3.5 
23 12.243 
> 3.5 
15 10.567 
Total 
50 13.408 
                                                                      TABLE NO: 18 
No of HCV
Positive(2)
Negative(48)
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 The p value is 0.001 
Here the comparison of serum albumin with mean IL 6 is done. This 
correlation is statistically significant since the p value is 0.001 
SAAG with Mean IL 6 
 
SAAG                              No of patients                          mean IL 6(pg/ml) 
< 1.5 
10 16.990 
1.6-2.2 
20 15.310 
> 2.2 
4 13.200 
Total 
34 15.556 
                                                                         TABLE NO: 19 
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 The p value is 0.215 
 
 
Here the comparison of SAAG with mean IL 6 is done. This correlation is not 
statistically significant since the p value is 0.215 
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Portal vein diameter and Mean IL6 
 
 
Portal vein diameter in 
mm                                    No of patients                               mean IL 6(pg/ml) 
10 
3 9.567 
11 
5 8.380 
12 
3 8.700 
13 
20 13.365 
14 
16 15.525 
15 
3 19.333 
Total 
50 13.408 
 
                                                                     TABLE NO: 20 
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The p value is 0.001 
 
Here the comparison of Portal vein diameter with mean IL 6 is done. This 
correlation is statistically significant since the p value is 0.001 
 
 
Variceal grading and Mean IL6 
 
 
Variceal grading                                 No of patients                            mean IL 6(pg/ml) 
Normal 
16 9.975 
1 
3 10.300 
2 
12 13.483 
3 
5 15.580 
4 
14 17.157 
Total 
50 13.408 
 
                                                                  TABLE NO: 21 
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The p value is 0.001 
 
Here the comparison of Portal vein variceal grading with mean IL 6 is done. 
This correlation is statistically significant since the p value is 0.001 
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Child class and Hb% 
 
   
Hb(gm%) 
Total < 6 6.1-8 8.1-10 > 10 
Child Class A Count 3 4 4 6 17 
% within 
Child Class 
17.6% 23.5% 23.5% 35.3% 100.0% 
% within HB 27.3% 33.3% 28.6% 46.2% 34.0% 
B Count 3 5 5 4 17 
% within 
Child Class 
17.6% 29.4% 29.4% 23.5% 100.0% 
% within HB 27.3% 41.7% 35.7% 30.8% 34.0% 
C Count 5 3 5 3 16 
% within 
Child Class 
31.3% 18.8% 31.3% 18.8% 100.0% 
% within HB 45.5% 25.0% 35.7% 23.1% 32.0% 
Total Count 11 12 14 13 50 
% within 
Child Class 
22.0% 24.0% 28.0% 26.0% 100.0% 
% within HB 100.0% 100.0% 100.0% 100.0% 100.0% 
                                                                                     TABLE NO:22
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The p value is 0 .876 
 
Here the comparison of Child class with Hemoglobin is done. This correlation 
is not statistically significant since the p value is 0.876 
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DISCUSSION: 
 
 
 
 
                          Jolanta-Zuwala-Jagiello et al observed that rising values of 
serum IL 6 level in patients with cirrhosis of varying causes are correlated with 
child pugh score while assessing disease severity. The values are 8.8pg/ml, 
12.3pg/ml and 18.9pg/ml for child pugh scrore A, B and C respectively [52].   
 
 In our study rising levels of serum IL 6 is noted while correlating with Child 
pugh score from A to C. The mean values of serum IL 6 level in patients with 
cirrhosis for Child class A, B and C are 8.876, 13.041 and 18.612 respectively. 
So our study is well correlating with the reference study since the p value for 
statistical significance is 0.001 
 
  From the above correlation mentioned serum IL 6 can be used as a marker 
while assessing disease severity in patients with liver cirrhosis in place of 
modified Child pugh score with acceptable statistical significance. 
 
Total no of alcoholics included in our study from the study population (50) is 45 
excluding 2 of hepatitis C and 3 of hepatitis B related cirrhosis. As vedat goral et 
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al mentioned, rising serum IL 6 level is independent of etiological factors [53] 
while assessing disease severity, this could not be possible in our study, since 
most of the patients included in our study are alcoholics with all other possible 
causes excluded.  
 
Total number of males and females are 47(94%) and 3(6%) respectively. Since 
prevalence of alcohol use is higher among males in our country, sex relationship 
with rising level of IL 6 level in our study could not be done. 
 
Not only the Child pugh score is correlating with serum interleukin 6 level with 
statistical significance, but also with other known parameters like mean total 
protein, Serum albumin, Portal vein diameter and Variceal grading on OGD 
scopy. 
 
Coming to the correlation of Child pugh score with mean total protein, Child 
class A, B and C is having mean total protein values of 6.41, 6.13 and 
5.71respectively. This correlation is observed to have statistical significance 
since the p value is 0.006. In this context, we can take even total protein values 
as a acceptable parameter to assess disease severity in place of modified child 
pugh score, particularly if there is difficulty in calculating this score. 
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The serum Albumin values for Child pugh class A, B and C are 3.582, 3.253, 
2.650 respectively. While taking serum albumin alone in assessing disease 
severity in liver cirrhosis, the statistical significance is well appreciated. The p 
value is around 0.001.Comparatively Serum albumin is having more statistical 
significance than total serum protein. 
 
Portal vein diameter calculated by Portal Doppler Study if greater than or equal 
to 13, it can be assumed that patient is having portal hypertension. In our study 
Portal vein diameter values for Child pugh class A, B and C are 11.82 mm, 13.29 
mm and 13.94 mm respectively and for total 50 patients it is 13 mm. It is 
correlated statistically with Child pugh class with p value of 0.001. Patients with 
child pugh class B and C definitely having portal hypertension since the mean 
values are 13.29 mm and 13.94 mm than patients with Child pugh class A. 
 
 Variceal grading by OGD scopy is significantly correlated with modified child 
pugh scoring system. The p value for this correlation is 0.001. Child class A 
having total number of patients 17 is observed in our study to have normal OGD 
scopy for 10 patients and variceal grading of 1 and 2 with 3patients each 
respectively.  
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Child class C having total number of 16 patients is observed to have normal 
OGD scopy for 0 patients and grade 4  for 11 patients and grade 3  for 2 patients. 
So increasing values of variceal grading is observed if Child class is increasing.   
 
Variceal grading also is correlated with serum IL 6 level with statistical 
significance. The p value for this correlation is 0.001. Raising levels are of mean 
serum interleukin 6 is proved with raising variceal grading score. The mean 
serum IL6 values for the variceal grading scores of normal, 1, 2, 3, 4 and 5 are 
9.975, 10.300, 13.483, 15.580, 17.157 and 13.408.  
 
So from this analysis we can consider serum IL 6 as a non-invasive parameter 
for the identification of varices in patients with liver cirrhosis, especially when 
facilities for OGD scopy are not available or  when patient cannot be shifted to 
OGD room if extremely ill. 
 
Portal vein diameter and serum interleukin 6 are correlated in patients with liver 
cirrhosis in our study. There is a positive correlation obtained with p value of 
0.001. The mean IL 6 values for the portal vein diameter 10mm, 11 mm, 12 mm, 
13 mm, 14 mm and 15 mm for 50 patients are 9.567, 8.380, 8.700, 13.365, 
15.525, 19.333 and 13.408 pg/ml respectively.  
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Presence of portal hypertension is considered if portal diameter is greater than 13 
mm. 39 patients having portal diameter of 13mm or greater have values of serum 
IL 6 between 13.365pg/ml and 19.333pg/ml. So serum IL 6 values greater than 
13 pg/ml can be better taken as a cut of value to say that presence of portal 
hypertension is suggested in patients of liver cirrhosis of mostly having alcoholic 
etiology.  
 
Though use of portal Doppler study is invaluable in patients with liver cirrhosis, 
IL 6 can be also considered as a marker for identification of portal hypertension 
as a noninvasive test. Statistical significance of correlation between serum IL 6 
and serum albumin is also proved to be good, since the p value is 0.001. So 
worsening of liver function with increasing levels of serum IL 6 is another 
inference from this study. 
 
Raising serum IL 6 level is correlated with prolongation of Prothrombin time. 
Significant statistical correlation is obtained with p value of 0.001. Mean serum 
interleukin values for prolongation of prothrombin time < 2, 2.1-4, 4.1-6, > 6 
are11.011, 14.760, 19.233 and 25.300pg/ml. So by knowing the value of raised 
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serum interleukin 6 in patients with liver cirrhosis, we can assume risk of 
bleeding in patients with liver cirrhosis. 
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LIMITATIONS OF STUDY 
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LIMITATIONS OF STUDY: 
 
 
 
 
 
Most of the patients included in this study are male. Since the prevalence of 
alcoholism is more in males in our country, Most of the patients included in 
this study are male alcoholics. So age and sex related correlation of this study 
are not possible. 
Since most of the patients are having the problem for 2 years in this study, 
correlation of duration of illness with child pugh class is not significant. 
Since prediabetes, prehypertension, and initial states of most of the 
inflammatory conditions are not considered in this study, confounding factors 
related with these factors are to be considered. 
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CONCLUSION : 
 
 
 
 
 Raised levels serum Interleukin 6 is correlated well with the modified child    
pugh scoring system in patients with liver cirrhosis of varying causes. So 
disease severity can be better assessed with Serum interleukin 6 in patients 
with liver cirrhosis alone or in association with modified child pugh score. 
Cost is considered in doing serum interleukin 6 assays. Though difficult, 
making this test available to all care level, will be helpful in assessing disease 
severity in patients with liver cirrhosis and in taking decisions regarding 
treatment quickly. 
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                                                  PROFORMA 
 
SERUM INTERLEUKIN 6 LEVEL IN PATIENTS WITH LIVER 
CIRRHOSIS OF ANY CAUSE AND ITS CORRELATION WITH CHILD 
PUGH SCORE IN ASSESSING DISEASE SEVERITY 
 
 
 
Name:      Age:   Sex: 
Address:       Occupation: 
Symptoms:
Abdominal pain 
Abdominal distention 
Swelling of legs 
jaundice 
yellowish disc of urine 
reduced urine output 
haemetemesis /melena 
haemetochezia 
fever/chills/rigor 
loss of weight  
loss of appetite 
altered sensorium 
mood changes            
sleep disturbance 
 
 
Past history: 
Known case of cirrhosis and portal 
hypertention-           (y/m) 
Diabetes mellitus/Bronchial 
asthma/COPD 
Hypertension/coronary artery 
disease 
Tuberculosis/renal disorder/thyroid 
disorder 
Previous h/o jaundice/blood 
transfusion/tattoing 
h/o drug abuse 
Other co-morbid illnesses 
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Personal history: 
Smoking 
     Alcoholism: period            (y/m) 
                    Quantity         (ml/day) 
               Alcohol           % 
               Branded/unbranded 
          Diet: veg/nonveg/ mixed 
General examination: 
 
 
Anthropometry: 
Height(in cm): Weight(in kg): 
 
PULSE: 
 
BLOOD PRESSURE:                              RR:                           TEMP: 
 
GENERAL EXAMINATION: 
 
SYSTEMIC EXAMINATION: 
 
CVS: RS: ABDOMEN:  CNS: 
INVESTIGATIONS: 
Hemogram RFT 
TC  cells/mm3 Glucose (F)  mg/dl 
DC  Glucose (PP)  mg/dl 
ESR  mm/hr Urea  mg/dl 
Hb  g/dl Creatinine  mg/dl 
PCV  % Na+  mEq/l 
Platelets  lakhs/mm3 K+  mEq/l 
RBCs  million/mm3 Urinanalysis 
Lipid profile Albumin  
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Total 
cholesterol 
 mg/dl Sugar  
LDL  mg/dl Deposits  
HDL  mg/dl Microalbuminuria  
Triglycerides  mg/dl Culture  
 
ECG: 
 
PT/INR:                         aPTT:      
 
LFT   
TB  mg/dl 
DB  mg/dl 
IB  mg/dl 
AST  IU 
ALT  IU 
ALP  IU 
TP  mg/dl 
ALB  mg/dl 
GLO  mg/dl 
 
Ascitic fluid analysis: albumin:                       
SAAG 
 
Portal Doppler study: 
 
 
 
ULTRASONOGRAM OF ABD: 
 
SERUM IL6 LEVEL 
 
 
 
 
 
 
 
 
CHILD PUGH 
SCORE 
1 2 3 Score Child 
cl 
 Ascites none Mild-
mod 
Sev/ref 5-6 A 
 
Encephalopathy 
none Mild(I-
II) 
Mod/sev(II-
IV) 
7-9 B 
Bilirubin(mg/dl) <2 2-3 >3 10-
15 
C 
Alb(g/dl) >3.5 3.5-
2.8 
<2.8 
PT(sec inc) 1-3 4-6 >6 
113 
 
 
 
 
 
 
114 
 
 
115 
 
  
116 
 
 
117 
 
 
118 
 
MASTER CHART 
ID IP NO AGE SEX DURATION Hb PLATELET PT TB ALP HBsAg HCV Ascites Encephalopathy 
1 110505 36 m 2 years 4.2 1.22 2 3.9 152 neg neg yes no 
2 112154 35 m IP 7.2 1.32 1 3.5 138 neg neg yes no 
3 112045 50 m 3 years 8.5 1.14 2 0.8 131 neg neg yes no 
4 107493 49 m 6 years 8.8 1.21 0.2 5.7 148 neg neg no no 
5 40342 42 m IP 9.2 1.02 1.2 1.6 112 neg neg yes no 
6 41899 46 m 2 years 4.8 1 1.8 1.4 106 neg neg no no 
7 40111 49 m 2 years 9.3 0.9 1.9 6.6 140 neg neg yes no 
8 59539 48 m 1 year 8 0.65 0.4 2.5 182 neg neg no no 
9 107001 45 m 6 years 6 1.8 4.2 8.8 194 neg neg no yes 
10 101113 50 m 5 years 7.2 1.15 0.4 1.9 116 neg neg yes no 
11 107934 41 m IP 9.4 0.8 2 0.8 62 neg neg yes no 
12 109519 39 m IP 7.1 1.16 0.6 10.6 237 neg neg yes no 
13 108484 44 m 7 years 10 0.66 5.2 3.6 151 neg neg no yes 
14 108614 48 m IP 7 1.8 0.1 1.2 92 neg neg yes no 
15 33801 43 f 3 .5 years 3.5 1 0.3 0.7 173 neg neg yes no 
16 6037/12 48 m 2 years 5.9 0.8 2.2 2.2 162 neg neg yes no 
17 114296 50 m 3 years 10.6 1.81. 1.7 2.8 93 neg neg yes no 
18 6171/11 48 m 1.5 years 9 1.1 1.7 1.8 95 neg neg no no 
19 41322 45 m 6 years 9 2.5 4.6 2.2 108 neg neg yes no 
20 113818 48 m 5 years 5.7 1.2 4.2 8.7 145 neg neg no yes 
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21 113690 32 m 4 years 8.6 1.56 2.1 15.8 268 neg neg yes no 
22 112489 45 m 1 year 14 2.2 0.4 7 173 neg neg yes no 
23 111697 40 m 3 years 7.4 1.25 2.3 5.9 153 neg neg no no 
24 113315 45 m 2.5 years 6.9 0.78 2.1 5.4 182 neg neg no no 
25 111345 38 m IP 12.8 1.8 1.2 1.6 115 neg neg no no 
26 63744 27 m 1 year 5.9 0.66 3.7 1.9 127 neg neg yes no 
27 108976 50 m 6 years 3.8 1.12 2.6 3.9 84 neg neg yes no 
28 101456 50 f Nonalcoholic 9.8 0.98 2.1 3 196 neg pos yes no 
29 101670 45 m 6 years 11.6 1.98 2.2 6.4 269 neg neg no no 
30 111094 38 m Nonalcoholic 9.2 1.8 2 2.5 178 pos neg yes no 
31 63980 41 m 2 years 7.8 1.12 4.7 4.1 211 neg neg yes no 
32 110567 38 m 4 years 6.8 1.32 3.2 5.6 112 neg neg no yes 
33 66890 41 m 3.5 years 5.7 0.78 1.2 1.1 112 neg neg yes yes 
34 109845 45 m 2 years 11 2.1 4 4.7 134 neg neg no no 
35 66980 49 m Nonalcoholic 10.7 1.12 1.7 2.5 173 pos neg no no 
36 103640 40 m IP 12.8 2.52 1.8 1.8 98 neg neg yes no 
37 62167 31 m IP 14.7 2.89 1.2 1.5 78 neg neg no no 
38 62289 35 m 1 year 10.9 1.23 2.5 2.7 167 neg neg yes no 
39 62289 48 m nonalcoholic 5.9 0.76 6.2 9.2 212 neg pos no yes 
40 666110 46 f nonalcoholic 6.7 0.91 0.2 1.6 145 pos neg yes no 
41 102876 39 m 4 years 8.9 2.98 3.2 7.2 187 neg neg yes no 
42 111004 47 m 1 years 9.8 1.76 1.2 2.8 101 neg neg yes no 
43 102834 41 m 2 years 7.9 1.09 1.8 2.2 178 neg neg yes no 
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44 111460 45 m 0.5 years 10.9 1.45 2.2 1.2 103 neg neg yes no 
45 110650 50 m 5 years 11.9 0.45 4.2 6.7 301 neg neg yes no 
46 113088 45 m IP 14 2.34 0.2 1.8 99 neg neg yes no 
47 114530 28 m IP 15.2 2.89 1.2 1.1 95 neg neg yes no 
48 112674 35 m 6 years 4.6 0.68 3.8 5 289 neg neg no yes 
49 61329 48 m 1 years 9 1.4 1.5 1.8 101 neg neg no no 
50 102399 50 m 2 years 7.8 1.56 3.2 2.1 143 neg neg yes no 
 
 
ID IP NO AGE SEX TP 
Serum 
Alb 
Ascitic 
Alb 
SAAG PV Diameter 
Variceal 
Grade 
Child 
Class 
Child 
Score 
IL6 
1 110505 36 m 6 3.2 2 1.2 14mm 2 B 8 14.2 
2 112154 35 m 5.8 3.2 1.2 2 13mm 2 B 9 10.3 
3 112045 50 m 5.9 2.9 1.2 1.5 14mm 4 B 7 12.2 
4 107493 49 m 5.7 2.9 1.2 1.7 13mm N B 7 12.4 
5 40342 42 m 6.5 3.8 nil NA 11mm N A 6 9.8 
6 41899 46 m 6.1 2.9 nil NA 10mm N A 6 9.2 
7 40111 49 m 5.7 2.6 1 1.6 14mm 4 C 11 17.4 
8 59539 48 m 6.1 3.2 nil NA 12mm N A 6 8.2 
9 107001 45 m 6.2 3.5 1.4 2.1 14mm 4 C 10 16.9 
10 101113 50 m 6.9 4.1 nil NA 13mm 2 A 5 11.9 
11 107934 41 m 6.8 3.7 nil NA 13mm 1 A 6 9 
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12 109519 39 m 6.8 3.2 1.1 2.1 14mm 4 C 10 16.1 
13 108484 44 m 6.5 3.7 1 2.7 14mm 2 C 10 16.4 
14 108614 48 m 6.2 3.5 nil NA 13mm N A 5 9.8 
15 33801 43 f 6 3.8 2.1 1.7 12mm N A 5 9.4 
16 6037/12 48 m 5.3 2.9 1.2 1.7 14mm 2 B 8 13.6 
17 114296 50 m 6.8 3.2 1.4 1.8 14mm 4 B 8 13.9 
18 6171/11 48 m 6 3.6 nil NA 13mm 3 A 5 7.3 
19 41322 45 m 5.7 2.8 1 1.8 15mm 4 C 10 18.3 
20 113818 48 m 5.2 2.2 1 1.2 13mm 2 C 12 19.7 
21 113690 32 m 5.7 2.9 1 1.9 14mm 4 C 10 18.1 
22 112489 45 m 6 3.8 1 2.8 13mm N B 7 10.7 
23 111697 40 m 6 3.2 1.3 1.9 14mm 2 B 8 12.8 
24 113315 45 m 5.7 3.9 1.6 2.3 13mm 4 B 7 11.6 
25 111345 38 m 5.9 3 nil NA 13mm 1 A 6 12.3 
26 63744 27 m 6.3 3.5 nil NA 13mm 2 A 6 9.1 
27 108976 50 m 6.2 2.5 1 1.4 14mm 4 C 10 16.8 
28 101456 50 f 6.2 3.8 1.2 2.6 14mm 3 B 8 14.1 
29 101670 45 m 7.8 2.8 0.9 1.9 15mm 2 C 10 16.8 
30 111094 38 m 6 2.9 1.6 1.3 13mm N B 8 13.9 
31 63980 41 m 5.2 2.7 1.1 1.6 14mm 4 C 11 21.2 
32 110567 38 m 5 2.2 1 1.2 13mm 4 C 12 23.4 
33 66890 41 m 6.4 3.6 1.4 2.2 11mm 2 B 5 13.6 
34 109845 45 m 5.9 2.5 1 1.5 14mm 3 C 10 17.1 
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35 66980 49 m 6.4 3.1 1.2 1.9 13mm N B 7 12.5 
36 103640 40 m 6.9 3.8 nil NA 10mm 1 A 6 9.6 
37 62167 31 m 6 3.4 nil NA 11mm N A 5 6.1 
38 62289 35 m 6.6 3.1 1.6 1.5 13mm N B 8 13.2 
39 62289 48 m 4.7 2 0.8 1.2 13mm 3 C 15 25.3 
40 666110 46 f 6.8 3.7 nil NA 13mm N A 6 8.4 
41 102876 39 m 5.1 2.6 1 1.6 14mm 4 C 10 13.5 
42 111004 47 m 6.2 3 1.2 1.8 13mm N B 9 13.7 
43 102834 41 m 6.4 3.2 1.8 1.4 14mm 3 B 8 14.1 
44 111460 45 m 7 3.9 nil NA 12mm 2 A 6 8.5 
45 110650 50 m 4 1.9 0.3 1.6 15mm 4 C 13 22.9 
46 113088 45 m 6.8 3.6 nil NA 10mm N A 6 9.9 
47 114530 28 m 6.5 3.9 nil NA 11mm N A 6 8.3 
48 112674 35 m 5.6 2.3 0.7 1.6 13mm 4 C 11 17.9 
49 61329 48 m 6.2 3.5 nil NA 11mm N A 5 4.1 
50 102399 50 m 6.8 3.4 1.4 2 13mm 2 B 8 14.9 
 
 
